Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Company Profile Abivax SA (PK) AAVXF

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials... see more

Showcase News Releases

Showcase news

Coelacanth Energy Inc.
Coelacanth Energy Increases Previously Announced Bought Deal Public Offering to C$80M
Coelacanth Energy Inc.
Canadian Investment Regulatory Organization Trade Resumption - CEI
PlasCred Circular Innovations Inc.
PlasCred Circular Innovations Inc. Announces Upsized Non-Brokered Private Placement Under Listed Issuer Financing Exemption

More Showcase News Releases »